General information about company

Scrip code*500412
NSE Symbol*TIRUMALCHM
MSEI Symbol*NOTLISTED
ISIN*INE338A01024
Name of companyThirumalai Chemicals Limited
Type of companyMain Board
Class of securityEquity
Date of start of financial year01-04-2025
Date of end of financial year31-03-2026
Date of board meeting when results were approved30-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange26-05-2026
Description of presentation currencyINR
Level of roundingLakhs
Reporting TypeQuarterly
Reporting QuarterFourth quarter
Nature of report standalone or consolidatedStandalone
Whether results are audited or unaudited for the quarter endedAudited
Whether results are audited or unaudited for the Year to date for current period ended/year endedAudited
Segment ReportingSingle segment
Description of single segmentChemical products and its intermediaries
Start date and time of board meeting30-05-2026 14:00
End date and time of board meeting30-05-2026 18:45
Whether cash flow statement is applicable on companyYes
Type of cash flow statementCash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualificationDeclaration of unmodified opinion
Whether the company has any related party?Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicNA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?Yes
Latest Date on which RPT policy is updated08-12-2025
Indicate Company website link for updated RPT policy of the Companyhttps://thirumalaichemicals.com/wp-content/uploads/2025/11/TCL_RPT-Policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?Yes
No. of times funds raised during the quarter1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?NoCompany has not made any defaults on loans.



Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-01-202601-04-2025
Date of end of reporting period31-03-202631-03-2026
Whether results are audited or unauditedAuditedAudited
Nature of report standalone or consolidatedStandaloneStandalone
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations25695135973
Other income8613355
Total income26556139328
2Expenses
(a)Cost of materials consumed1215186310
(b)Purchases of stock-in-trade587224885
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade22301232
(d)Employee benefit expense 14425579
(e)Finance costs20667693
(f)Depreciation, depletion and amortisation expense7523341
(g)Other Expenses
1Other Expenses388519309
Total other expenses388519309
Total expenses28398148349
3Total profit before exceptional items and tax-1842-9021
4Exceptional items -444-444
5Total profit before tax-2286-9465
6Tax expense
7Current tax-387-387
8Deferred tax-816-2538
9Total tax expenses-1203-2925
10Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement00
11Net Profit Loss for the period from continuing operations-1083-6540
12Profit (loss) from discontinued operations before tax00
13Tax expense of discontinued operations00
14Net profit (loss) from discontinued operation after tax00
15Share of profit (loss) of associates and joint ventures accounted for using equity method00
16Total profit (loss) for period-1083-6540
17Other comprehensive income net of taxes-1865-3895
18Total Comprehensive Income for the period-2948-10435
19Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21Details of equity share capital
Paid-up equity share capital12061206
Face value of equity share capital11
22Reserves excluding revaluation reserve148574
23Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations-0.9-5.81
Diluted earnings (loss) per share from continuing operations-0.9-5.81
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations00
Diluted earnings (loss) per share from discontinued operations00
iiiEarnings per equity share (for continuing and discontinued operations)
Basic earnings (loss) per share from continuing and discontinued operations-0.9-5.81
Diluted earnings (loss) per share from continuing and discontinued operations-0.9-5.81
24Debt equity ratioTextual Information( 1)
25Debt service coverage ratioTextual Information( 2)
26Interest service coverage ratioTextual Information( 3)
27Disclosure of notes on financial resultsTextual Information(4)

Text Block

Textual Information(4)AS MENTIONED IN SUBMITTED PDF



Statement of Asset and Liabilities

ParticularsYear ended (dd-mm-yyyy)
Date of start of reporting period01-04-2025
Date of end of reporting period31-03-2026
Whether results are audited or unauditedAudited
Nature of report standalone or consolidatedStandalone
Assets
1 Non-current assets
Property, plant and equipment36579
Capital work-in-progress260
Investment property0
Goodwill0
Other intangible assets5
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments151181
Trade receivables, non-current0
Loans, non-current0
Other non-current financial assets
1Other financial assets302
2
3
4
5
Details of other non-current financial assets
Total of other non-current financial assets302
Total non-current financial assets151483
Deferred tax assets (net)
Other non-current assets
1Income tax assets(net)436
2Other non-current assets239
3
4
5
Details of other non-current assets
Total of other non-current assets675
Total non-current assets189002
2Current assets
Inventories10484
Current financial asset
Current investments0
Trade receivables, current32746
Cash and cash equivalents2306
Bank balance other than cash and cash equivalents778
Loans, current11899
Other current financial assets
1Other current financial assets743
2
3
4
5
Details of other current financial assets
Total of Other current financial assets743
Total current financial assets48472
Current tax assets (net)
Other current assets
1Income Tax Assets(net)1069
2Other current assets1361
3
4
5
Details of other current assets
Total of other current assets2430
Total current assets61386
3Non-current assets classified as held for sale
4Regulatory deferral account debit balances and related deferred tax Assets
Total assets250388
Equity and liabilities
1Equity
Equity attributable to owners of parent
Equity share capital1206
Other equity148574
Total equity attributable to owners of parent149780
Non controlling interest
Total equity149780
2Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current48954
Trade Payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1
2
3
4
5
Details of other non-current financial liabilities
Total of other non-current financial liabilities
Total non-current financial liabilities48954
Provisions, non-current1015
Deferred tax liabilities (net)2815
Deferred government grants, Non-current
Other non-current liabilities
1
2
3
4
5
Details of other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities52784
Current liabilities
Current financial liabilities
Borrowings, current27038
Trade Payables, current
(A) Total outstanding dues of micro enterprises and small enterprises337
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises17899
Total Trade payable18236
Other current financial liabilities
1Other financial liabilities996
2
3
4
5
Details of other current financial liabilities
Total of other current financial liabilities996
Total current financial liabilities46270
Other current liabilities
1Other current liabilities801
2
3
4
5
Details of other current liabilities
Total of other current liabilities801
Provisions, current753
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities47824
3Liabilities directly associated with assets in disposal group classified as held for sale0
4Regulatory deferral account credit balances and related deferred tax liability0
Total liabilities100608
Total equity and liabilities250388
Disclosure of notes on assets and liabilitiesTextual Information(1)

Text Block

Textual Information(1)AS MENTIONED IN SUBMITTED PDF



Other Comprehensive Income

Date of start of reporting period01-01-202601-04-2025
Date of end of reporting period31-03-202631-03-2026
Whether results are audited or unauditedAuditedAudited
Nature of report standalone or consolidatedStandaloneStandalone
Other comprehensive income [Abstract]
1Amount of items that will not be reclassified to profit and loss
1Remeasurement of defined benefit plans46.00-8.00
2Equity instruments through other comprehensive income, net-2216.00-4538.00
3Income tax relating to items that will not be reclassified to profit or loss 305.00651.00
Total Amount of items that will not be reclassified to profit and loss-1865.00-3895.00
2Income tax relating to items that will not be reclassified to profit or loss 0.000.00
3Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4Income tax relating to items that will be reclassified to profit or loss
5Total Other comprehensive income-1865.00-3895.00


Cash flow statement, indirect

ParticularsYear ended (dd-mm-yyyy)
Date of start of reporting period01-04-2025
Date of end of reporting period31-03-2026
Whether results are audited or unauditedAudited
Nature of report standalone or consolidatedStandalone
Part IBlue color marked fields are non-mandatory.
1Statement of cash flows
Cash flows from used in operating activities
Profit before tax-9465
2Adjustments for reconcile profit (loss)
Adjustments for finance costs7693
Adjustments for decrease (increase) in inventories5839
Adjustments for decrease (increase) in trade receivables, current-8548
Adjustments for decrease (increase) in trade receivables, non-current0
Adjustments for decrease (increase) in other current assets1219
Adjustments for decrease (increase) in other non-current assets0
Adjustments for other financial assets, non-current0
Adjustments for other financial assets, current4215
Adjustments for other bank balances0
Adjustments for increase (decrease) in trade payables, current-22542
Adjustments for increase (decrease) in trade payables, non-current0
Adjustments for increase (decrease) in other current liabilities-82
Adjustments for increase (decrease) in other non-current liabilities0
Adjustments for depreciation and amortisation expense3341
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss444
Adjustments for provisions, current324
Adjustments for provisions, non-current0
Adjustments for other financial liabilities, current-1059
Adjustments for other financial liabilities, non-current0
Adjustments for unrealised foreign exchange losses gains659
Adjustments for dividend income282
Adjustments for interest income930
Adjustments for share-based payments0
Adjustments for fair value losses (gains)0
Adjustments for undistributed profits of associates0
Other adjustments for which cash effects are investing or financing cash flow0
Other adjustments to reconcile profit (loss)0
Other adjustments for non-cash items-1060
Share of profit and loss from partnership firm or association of persons or limited liability partnerships0
Total adjustments for reconcile profit (loss)-10769
Net cash flows from (used in) operations-20234
Dividends received0
Interest paid0
Interest received0
Income taxes paid (refund)328
Other inflows (outflows) of cash0
Net cash flows from (used in) operating activities-20562
3Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses0
Cash flows used in obtaining control of subsidiaries or other businesses0
Other cash receipts from sales of equity or debt instruments of other entities0
Other cash payments to acquire equity or debt instruments of other entities40313
Other cash receipts from sales of interests in joint ventures0
Other cash payments to acquire interests in joint ventures0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships0
Proceeds from sales of property, plant and equipment11
Purchase of property, plant and equipment1765
Proceeds from sales of investment property0
Purchase of investment property0
Proceeds from sales of intangible assets0
Purchase of intangible assets0
Proceeds from sales of intangible assets under development0
Purchase of intangible assets under development0
Proceeds from sales of goodwill0
Purchase of goodwill0
Proceeds from biological assets other than bearer plants0
Purchase of biological assets other than bearer plants0
Proceeds from government grants0
Proceeds from sales of other long-term assets0
Purchase of other long-term assets0
Cash advances and loans made to other parties6085
Cash receipts from repayment of advances and loans made to other parties0
Cash payments for future contracts, forward contracts, option contracts and swap contracts0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts0
Dividends received227
Interest received512
Income taxes paid (refund)0
Other inflows (outflows) of cash-562
Net cash flows from (used in) investing activities-47975
4Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries0
Payments from changes in ownership interests in subsidiaries0
Proceeds from issuing shares49549
Proceeds from issuing other equity instruments0
Payments to acquire or redeem entity's shares0
Payments of other equity instruments0
Proceeds from exercise of stock options0
Proceeds from issuing debentures notes bonds etc0
Proceeds from borrowings98602
Repayments of borrowings76189
Payments of lease liabilities277
Dividends paid0
Interest paid7290
Income taxes paid (refund)0
Other inflows (outflows) of cash0
Net cash flows from (used in) financing activities64395
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes-4142
5Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents72
Net increase (decrease) in cash and cash equivalents-4070
Cash and cash equivalents cash flow statement at beginning of period6376
Cash and cash equivalents cash flow statement at end of period2306



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr. No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of the related party transaction ratified by the audit committeeDate of Audit Committee Meeting where the ratification was approvedValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investments
NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment)Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)Notes
1THIRUMALAI CHEMICALS LTDAAACT2015MMr. R.ParthasarathyAAHPP7475KMDRemunerationNil162.5400
2THIRUMALAI CHEMICALS LTDAAACT2015MMrs. Ramya BharathramAGDPB4141JMD & CFORemunerationNil154.4100
3THIRUMALAI CHEMICALS LTDAAACT2015MMR. C.G SethuramAALPS5433QGroup Chief Executive OfficerRemunerationNil000
4THIRUMALAI CHEMICALS LTDAAACT2015MMr.Sanjay SinhaAAMPS2498CChief Executive OfficerRemunerationNil202.4700
5THIRUMALAI CHEMICALS LTDAAACT2015MMR. Pramodkumar RAMIPP1268K Company SecretaryRemunerationNil8.5200
6THIRUMALAI CHEMICALS LTDAAACT2015MMR. Aditya SharmaBNHPS3253G Company SecretaryRemunerationNil3.0700
7THIRUMALAI CHEMICALS LTDAAACT2015MUltramarine and Pigments LimitedAAACU0718QPromoters GroupPurchase of goods or services32Yes10.51.891.89
8THIRUMALAI CHEMICALS LTDAAACT2015MUltramarine and Pigments LimitedAAACU0718QPromoters GroupSale of goods or services50Yes19.884.174.56
9THIRUMALAI CHEMICALS LTDAAACT2015MUltramarine and Pigments LimitedAAACU0718QPromoters GroupAny other transactionDeposit payable0Nil0140
10THIRUMALAI CHEMICALS LTDAAACT2015MUltramarine and Pigments LimitedAAACU0718QPromoters GroupAny other transactionLoan payable0Yes020002000
11THIRUMALAI CHEMICALS LTDAAACT2015MUltramarine and Pigments LimitedAAACU0718QPromoters GroupAny other transactionInterest paid185Yes40.0400
12THIRUMALAI CHEMICALS LTDAAACT2015MUltramarine and Pigments LimitedAAACU0718QPromoters GroupAny other transactionInvestment to subsidiaryNil019703.0415390.84
13THIRUMALAI CHEMICALS LTDAAACT2015MUltramarine and Pigments LimitedAAACU0718QPromoters GroupAny other transactionDividend ReceivedNil226.7400
14THIRUMALAI CHEMICALS LTDAAACT2015MThirumalai Charity TrustAAATT0087AOther related partyPurchase of goods or services20Yes8.140.347.49
15THIRUMALAI CHEMICALS LTDAAACT2015MThirumalai Charity TrustAAATT0087AOther related partyAny other transactionCSR Donation230Yes110.7700
16THIRUMALAI CHEMICALS LTDAAACT2015MTCL INTERMEDIATES PVT LTDAAJCT0669GPromoters GroupPurchase of goods or services810Yes540.0888.73742.64
17THIRUMALAI CHEMICALS LTDAAACT2015MTCL INTERMEDIATES PVT LTDAAJCT0669GPromoters GroupSale of goods or services25152.2Yes11413.2918399.8518056.85
18THIRUMALAI CHEMICALS LTDAAACT2015MTCL INTERMEDIATES PVT LTDAAJCT0669GPromoters GroupAny other transactionLoan to subsidiaryNil005450
19THIRUMALAI CHEMICALS LTDAAACT2015MTCL INTERMEDIATES PVT LTDAAJCT0669GPromoters GroupAny other transactionInterest received943Yes266.3600
20THIRUMALAI CHEMICALS LTDAAACT2015MTCL INTERMEDIATES PVT LTDAAJCT0669GPromoters GroupInvestmentNil023875.0823875.08
21THIRUMALAI CHEMICALS LTDAAACT2015MOPTIMISTIC ORGANIC SDN BHDZZZZZ9999ZPromoters GroupPurchase of goods or services250Yes13.2237.830
22THIRUMALAI CHEMICALS LTDAAACT2015MOPTIMISTIC ORGANIC SDN BHDZZZZZ9999ZPromoters GroupSale of goods or services101.5Yes0105.320
23THIRUMALAI CHEMICALS LTDAAACT2015MOPTIMISTIC ORGANIC SDN BHDZZZZZ9999ZPromoters GroupAny other transactionInvestment to subsidiaryNil03082.833082.83
24THIRUMALAI CHEMICALS LTDAAACT2015MTCL GLOBAL BVZZZZZ9999ZPromoters GroupPurchase of goods or services360Yes12.37156.5520.37
25THIRUMALAI CHEMICALS LTDAAACT2015MTCL GLOBAL BVZZZZZ9999ZPromoters GroupSale of goods or services5000Yes1307.34608.3349.35
26THIRUMALAI CHEMICALS LTDAAACT2015MTCL GLOBAL BVZZZZZ9999ZPromoters GroupAny other transactionInvestment to subsidiaryNil097697.09101528.87
27THIRUMALAI CHEMICALS LTDAAACT2015MTCL GLOBAL BVZZZZZ9999ZPromoters GroupAny other transactionLoan to subsidiaryNil06035.710
28THIRUMALAI CHEMICALS LTDAAACT2015MTCL SPECIALTIES LLCZZZZZ9999ZPromoters GroupPurchase of goods or services0Yes8.038.030
29THIRUMALAI CHEMICALS LTDAAACT2015MTCL SPECIALTIES LLCZZZZZ9999ZPromoters GroupSale of goods or services57000Yes9033.87-4200.275345.93
30THIRUMALAI CHEMICALS LTDAAACT2015MTCL SPECIALTIES LLCZZZZZ9999ZPromoters GroupAny other transactionInvestment to subsidiaryNil01531.551844.42
31THIRUMALAI CHEMICALS LTDAAACT2015MCheminvest Pte LtdZZZZZ9999ZPromoters GroupAny other transactionInvestment to subsidiaryNil05428.315428.31
32THIRUMALAI CHEMICALS LTDAAACT2015MICE Steel 1 Pvt LtdAACCD7385EOther related partyPurchase of goods or servicesNil02.822.82
33THIRUMALAI CHEMICALS LTDAAACT2015MMr. Raj KatariaAAPPK0522QOther related partyAny other transactionSitting fees paidNil5.100
34THIRUMALAI CHEMICALS LTDAAACT2015MMr. Arun RamanathanABMPR1919AOther related partyAny other transactionSitting fees paidNil000
35THIRUMALAI CHEMICALS LTDAAACT2015MMr. Rajeev M. PandiaAAEPP3004DOther related partyAny other transactionSitting fees paidNil9.300
36THIRUMALAI CHEMICALS LTDAAACT2015MMrs. Bhama KrishnamurthyAAPPK0269AOther related partyAny other transactionSitting fees paidNil7.500
37THIRUMALAI CHEMICALS LTDAAACT2015MMr. Dhruv MoondhraAGQPM2062COther related partyAny other transactionSitting fees paidNil000
38THIRUMALAI CHEMICALS LTDAAACT2015MMr. Arun AlagappanAACPA9627POther related partyAny other transactionSitting fees paidNil2.100
39THIRUMALAI CHEMICALS LTDAAACT2015MMr R SampathAALPS9616DPromoters GroupAny other transactionSitting fees paidNil000
40THIRUMALAI CHEMICALS LTDAAACT2015MMr. M SomasundaramAAXPS0381FOther related partyAny other transactionSitting fees paidNil6.600
41THIRUMALAI CHEMICALS LTDAAACT2015MMs.SabithaAAZPS2302NOther related partyAny other transactionSitting fees paidNil6.300
42THIRUMALAI CHEMICALS LTDAAACT2015MMr.Meghav Deepak MehtaAKLPM5611JOther related partyAny other transactionSitting fees paidNil5.100
Total value of transaction during the reporting period23583.64



Details of Impact of Audit Qualification

Whether results are audited or unauditedAudited
Declaration of unmodified opinion or statement on impact of audit qualificationDeclaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone resultsYes
Audit firm's nameWhether the firm holds a valid peer review certificate issued by Peer Review Board of ICAICertificate valid upto
1Walker Chandiok & Co LLPYes31-05-2028



Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Mode of Fund RaisingPreferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds23-12-2025
Amount Raised5613.99
Report filed for Quarter ended31-03-2026
Monitoring AgencyNot applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raisedNo
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / VariationNot applicable
Comments of the Audit Committee after reviewNIL
Comments of the auditors, if anyNIL


Sr.Original ObjectModified Object, if anyOriginal AllocationModified allocation, if anyFunds UtilisedAmount of Deviation/Variation for the quarter according to applicable objectRemarks if any
1Investment in TCL global BV for onward investment eventually into TCL Specialties LLC in the United States of America to finance capital expenditureNIL35993584.623584.620
2General Corporate PurposesNIL20002013.572012.590
3Issue ExpensesNIL1515.815.80


Signatory Details

Name of signatoryRamya Bharathram
Designation of personManaging Director
PlaceChennai
Date30-05-2026